Rate My Professor Niwanthi Rajapakse

Rajapakse has produced 49 scholarly works from 2002 to 2024, accessible via UQ eSpace, with prominent publications such as 'High fibre diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice' (Circulation, 2017), 'SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein' (Molecular Psychiatry, 2023), 'Chemokine receptor CXCR7 antagonism ameliorates cardiac and renal fibrosis induced by mineralocorticoid excess' (Scientific Reports, 2024), 'Stimulation of angiotensin converting enzyme 2: A novel treatment strategy for diabetic nephropathy' (Frontiers in Physiology, 2022), 'Endothelial-specific overexpression of cationic amino acid transporter-1 prevents loss of kidney function in heart failure' (Clinical Science, 2020), 'Impaired L-arginine-nitric oxide pathway contributes to the pathogenesis of resistant hypertension' (Clinical Science, 2019), and 'N-Acetylcysteine Attenuates the Development of Renal Fibrosis in Transgenic Mice with Dilated Cardiomyopathy' (Scientific Reports, 2017). She has obtained funding including the UQ Major Equipment and Infrastructure grant for the Vevo 3100 Imaging System (2019), and project grants from the US Alzheimer’s Association and National Institute of Health as Chief Investigator B (administered via Monash University). In 2024, she principal advised two PhD completions: 'Stimulating the counter-regulatory renin-angiotensin system: a novel approach to prevent Alzheimer’s disease' and 'Novel Treatments for Cardiorenal Disease and Diabetes Mellitus: Role of Cationic Amino Acid Transporter-1 and Angiotensin Converting Enzyme 2'. She coordinates courses like BIOM1052 and is a media expert on cardiorenal topics.